The bank said roughly half of the index-level earnings upside in the first quarter was driven by one-time items, including tariff add-backs and asset mark-ups. Stripping those out, the beat aligned ...

N.P. “Narv” Narvekar, the chief executive officer of Harvard University’s $56.9 billion endowment, has notified the board of ...

China’s United Nations ambassador on Friday opposed a proposed resolution by the United States and Bahrain regarding the Strait of Hormuz, stating the measure lacks appropriate content and timing. The ...

Investing.com -- Arm Holdings Plc ( NASDAQ:ARM) is facing a formal antitrust investigation by the U.S. Federal Trade ...

Amgen Inc (NASDAQ:AMGN) shares fell 2.1% Friday following developments related to Tavneos, a drug for rare kidney diseases ...

Investing.com - PwC and Anthropic announced an expansion of their strategic alliance to deploy Claude across PwC’s workforce and client engagements. The collaboration includes rolling out Claude Code ...

The Federal Aviation Administration announced Friday it is reducing its staffing target for air traffic controllers to 12,563, down from 14,633, as part of an eff ...

Should you invest $2,000 in ELABS right now? ProPicks AI evaluates ELABS alongside thousands of other companies every month using 100+ financial metrics. Using powerful AI to generate exciting stock ...

Sri Lanka’s services and manufacturing sectors both moved into contraction territory in April, according to data released by the Central Bank of Sri Lanka. The services sector Purchasing Managers’ ...

May, Bitcoin is being influenced by two different trends. On one side, institutional demand is improving, with stronger inflows into spot Bitcoin ET ...

Jiuzi Holdings Inc. (NASDAQ:JZXN) shares rose 19.5% in premarket trading Friday after the company announced a strategic partnership focused on artificial intelligence technology development. The ...

Aardvark Therapeutics Inc (NASDAQ:AARD) shares fell 32.4% in premarket trading Friday after the Food and Drug Administration placed a full clinical hold on the company’s investigational new drug ...